The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review

Clinical Reviews in Allergy and Immunology

Volumn 48, Issue 2-3, 2015, Pages 301-315

  Sun, Ying ^a,b   Zhang, Weici ^a   Li, Baosen ^b   Zou, Zhengsheng ^b   Selmi, Carlo ^c   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BEIJING 302 HOSPITAL   (China)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Autoantibody; Cholestasis; Epithelitis; Sicca syndrome; Tolerance breakdown

Indexed keywords

AUTOANTIBODY;

APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B LYMPHOCYTE; COMPLICATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; LIVER CIRRHOSIS, BILIARY; METABOLISM; PREVALENCE; SEX DIFFERENCE; SJOGREN'S SYNDROME; T LYMPHOCYTE SUBPOPULATION;

APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER CIRRHOSIS, BILIARY; PREVALENCE; SEX FACTORS; SJOGREN'S SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 84939997597     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-015-8471-1     Document Type: Article

References (233)

1. Tsianos EV, Hoofnagle JH, Fox PC et al (1990) Sjogren's syndrome in patients with primary biliary cirrhosis. Hepatology 11:730–734
2. Giovannini A, Ballardini G, Amatetti S, Bonazzoli P, Bianchi FB (1985) Patterns of lacrimal dysfunction in primary biliary cirrhosis. Br J Ophthalmol 69:832–835
3. Golding PL, Bown R, Mason AM, Taylor E (1970) "Sicca complex" in liver disease. Br Med J 4:340–342
4. McFarlane IG, Wojcicka BM, Tsantoulas DC et al (1976) Cellular immune responses to salivary antigens in autoimmune liver disease with sicca syndrome. Clin Exp Immunol 25:389–395
5. Alarcon-Segovia D, Diaz-Jouanen E, Fishbein E (1973) Features of Sjogren's syndrome in primary biliary cirrhosis. Ann Intern Med 79:31–36
6. Carpenter GH, Proctor GB, Pankhurst CL, O'Donohue J, Scott D, Hunnable MP (2000) Sialochemical markers of salivary gland involvement with Sjogren's syndrome secondary to rheumatoid arthritis and primary biliary cirrhosis. J Oral Pathol Med 29:452–459
7. Epstein O, Chapman RW, Lake-Bakaar G, Foo AY, Rosalki SB, Sherlock S (1982) The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology 83:1177–1182
8. Floreani A, Baragiotta A, Leone MG, Baldo V, Naccarato R (2003) Primary biliary cirrhosis and hepatitis C virus infection. Am J Gastroenterol 98:2757–2762
9. Selmi C, Meroni PL, Gershwin ME (2012) Primary biliary cirrhosis and Sjögren’s syndrome: autoimmune epithelitis. J Autoimmun 39:34–42
10. Gershwin ME, Selmi C, Worman HJ et al (2005) Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42:1194–1202
11. Liu B, Zhang FC, Zhang ZL, Zhang W, Gao LX (2008) Interstitial lung disease and Sjogren's syndrome in primary biliary cirrhosis: a causal or casual association? Clin Rheumatol 27:1299–1306
12. Uddenfeldt P, Danielsson A, Forssell A, Holm M, Ostberg Y (1991) Features of Sjogren's syndrome in patients with primary biliary cirrhosis. J Intern Med 230:443–448
13. Gao LX, Wang L, Zhang FC (2013) Clinical characteristics of primary biliary cirrhosis complicating Sjogren syndrome. Zhonghua Yi Xue Za Zhi 93:3457–3459
14. Hansen BU, Lindgren S, Eriksson S et al (1988) Clinical and immunological features of Sjogren's syndrome in patients with primary biliary cirrhosis with emphasis on focal sialadenitis. Acta Med Scand 224:611–619
15. Dorner T, Held C, Trebeljahr G, Lukowsky A, Yamamoto K, Hiepe F (1994) Serologic characteristics in primary biliary cirrhosis associated with sicca syndrome. Scand J Gastroenterol 29:655–660
16. Selmi C, Bowlus CL, Gershwin ME, Coppel RL (2011) Primary biliary cirrhosis. Lancet 377:1600–1609
17. Borchers AT, Naguwa SM, Keen CL, Gershwin ME (2003) Immunopathogenesis of Sjogren's syndrome. Clin Rev Allergy Immunol 25:89–104
18. Floreani A, Franceschet I, Cazzagon N, et al. (2014) Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol
19. Coll J, Rives A, Grino MC, Setoain J, Vivancos J, Balcells A (1987) Prevalence of Sjogren's syndrome in autoimmune diseases. Ann Rheum Dis 46:286–289
20. Skopouli FN, Barbatis C, Moutsopoulos HM (1994) Liver involvement in primary Sjögren's syndrome. Rheumatology 33:745–748
21. Speight P, Cruchley A, Williams D (1990) Quantification of plasma cells in labial salivary glands: increased expression of IgM in Sjögren's syndrome. J Oral Pathol Med 19:126–130
22. Selmi C, Meroni PL, Gershwin ME (2012) Primary biliary cirrhosis and Sjogren's syndrome: autoimmune epithelitis. J Autoimmun 39:34–42
23. Moutsopoulos HM (1994) Sjogren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 72:162–165
24. Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 164:1275–1284
25. Bayetto K, Logan RM (2010) Sjogren's syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J 55(Suppl 1):39–47
26. Al-Hashimi I (2005) Xerostomia secondary to Sjogren's syndrome in the elderly: recognition and management. Drugs Aging 22:887–899
27. Bernacchi E, Amato L, Parodi A et al (2004) Sjogren's syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin Exp Rheumatol 22:55–62
28. Lindor KD, Gershwin ME, Poupon R et al (2009) Primary biliary cirrhosis. Hepatology 50:291–308
29. Tsuneyama K, Van De Water J, Nakanuma Y et al (1994) Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC‐E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjogren's syndrome. Hepatology 20:893–898
30. Joplin RE, Johnson GD, Matthews JB et al (1994) Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC‐E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis. Hepatology 19:1375–1380
31. Granito A, Muratori P, Muratori L et al (2007) Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther 26:831–838
32. Selmi C, Mayo MJ, Bach N et al (2004) Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127:485–492
33. Selmi C (2008) The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract Res Clin Rheumatol 22:913–922
34. Invernizzi P, Miozzo M, Selmi C et al (2005) X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 175:575–578
35. Miozzo M, Selmi C, Gentilin B et al (2007) Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 46:456–462
36. Tsuda M, Torgerson TR, Selmi C et al (2010) The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun 35:265–268
37. Lessard CJ, Li H, Adrianto I et al (2013) Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome. Nat Genet 45:1284–1292
38. Li Y, Zhang K, Chen H et al (2013) A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23. Nat Genet 45:1361–1365
39. Burbelo PD, Ambatipudi K, Alevizos I (2014) Genome-wide association studies in Sjogren's syndrome: what do the genes tell us about disease pathogenesis? Autoimmun Rev 13:756–761
40. Csepregi A, Szodoray P, Zeher M (2002) Do autoantibodies predict autoimmune liver disease in primary Sjögren's syndrome? Data of 180 patients upon a 5 year follow‐up. Scand J Immunol 56:623–629
41. Shiboski SC, Shiboski CH, Criswell L et al (2012) American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 64:475–487
42. Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J (2005) Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 25:298–310
43. Worman HJ, Courvalin JC (2003) Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev 2:211–217
44. Granito A, Muratori P, Quarneti C, Pappas G, Cicola R, Muratori L (2012) Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn 12:65–74
45. Watt FE, James OF, Jones DE (2004) Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 97:397–406
46. Sherlock S, Scheuer PJ (1973) The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 289:674–678
47. Reynoso-Paz S, Leung PS, Van De Water J et al (2000) Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis. Hepatology 31:24–29
48. Medina J, Sanz-Cameno P, García-Buey L, Martín-Vílchez S, López-Cabrera M, Moreno-Otero R (2005) Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study. J Hepatol 42:124–131
49. Mitsias D, Kapsogeorgou E, Moutsopoulos H (2006) The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjögren’s syndrome (autoimmune epithelitis). Lupus 15:255–261
50. Dienes H, Lohse A, Gerken G et al (1997) Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 431:119–124
51. Pflugfelder SC (2004) Antiinflammatory therapy for dry eye. Am J Ophthalmol 137:337–342
52. Tsunawaki S, Nakamura S, Ohyama Y et al (2002) Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjögren's syndrome. J Rheumatol 29:1884–1896
53. Allina J, Hu B, Sullivan DM et al (2006) T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27:232–241
54. Allina J, Stanca CM, Garber J et al (2008) Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun 30:238–245
55. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K (1997) Nuclear DNA fragmentation and expression of Bcl‐2 in primary biliary cirrhosis. Hepatology 25:1077–1084
56. Manoussakis MN, Moutsopoulos HM (2000) Sjogren's syndrome: autoimmune epithelitis. Bailliere Best Pract Res Clin Rheumatol 14:73–95
57. Tsuneyama K, Van de Water J, Nakanuma Y et al (1994) Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC-E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjogren's syndrome. Hepatology 20:893–898
58. Manganelli P, Quaini F, Andreoli AM et al (1997) Quantitative analysis of apoptosis and bcl-2 in Sjogren's syndrome. J Rheumatol 24:1552–1557
59. Kong L, Ogawa N, McGuff HS et al (1998) Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol 88:133–141
60. Harada K, Furubo S, Ozaki S, Hiramatsu K, Sudo Y, Nakanuma Y (2001) Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis. J Hepatol 34:500–506
61. Macdonald P, Palmer J, Kirby J, Jones D (2004) Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex. Clin Exp Immunol 136:559–567
62. Rong G, Zhong R, Lleo A et al (2011) Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis. Hepatology 54:196–203
63. Ravagnan L, Roumier T, Kroemer G (2002) Mitochondria, the killer organelles and their weapons. J Cell Physiol 192:131–137
64. Ohlsson M, Jonsson R, Brokstad K (2002) Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scand J Immunol 56:456–469
65. Monks J, Rosner D, Geske FJ et al (2005) Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ 12:107–114
66. Mochizuki H, Goto K, Mori H, Mizuno Y (1996) Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 137:120–123
67. Hauk V, Fraccaroli L, Grasso E et al (2014) Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis. Clin Exp Immunol 177:662–670
68. Harada K, Ozaki S, Gershwin ME, Nakanuma Y (1997) Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 26:1399–1405
69. Tinmouth J, Lee M, Wanless IR, Tsui FW, Inman R, Heathcote EJ (2002) Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 22:228–234
70. Manganelli P, Quaini F, Andreoli A et al (1997) Quantitative analysis of apoptosis and bcl-2 in Sjogren's syndrome. J Rheumatol 24:1552–1557
71. Jimenez F, Aiba‐Masago S, Al Hashimi I et al (2002) Activated caspase 3 and cleaved poly (ADP‐ribose) polymerase in salivary epithelium suggest a pathogenetic mechanism for Sjögren's syndrome. Rheumatology 41:338–342
72. Parnaik R, Raff MC, Scholes J (2000) Differences between the clearance of apoptotic cells by professional and non-professional phagocytes. Curr Biol 10:857–860
73. Jelinek DF, Lipsky PE (1987) Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1. J Immunol 139:2970–2976
74. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y (1998) Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. Lab Invest 78:89–100
75. Shimoda S, Harada K, Niiro H et al (2008) Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology 47:958–965
76. Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S (2002) Involvement of the interferon‐γ-induced T cell–attracting chemokines, interferon‐γ–inducible 10‐kd protein (CXCL10) and monokine induced by interferon‐γ (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis Rheum 46:2730–2741
77. Yokomori H, Oda M, Ogi M et al (2005) Expression of adhesion molecules on mature cholangiocytes in canal of Hering and bile ductules in wedge biopsy samples of primary biliary cirrhosis. World J Gastroenterol 11:4382
78. Afford SC, Humphreys EH, Reid DT et al (2014) Vascular cell adhesion molecule 1 expression by biliary epithelium promotes persistence of inflammation by inhibiting effector T‐cell apoptosis. Hepatology 59:1932–1943
79. Tsuneyama K, Harada K, Yasoshima M, Kaji K, Gershwin ME, Nakanuma Y (1998) Expression of co‐stimulatory factor B7‐2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study. J Pathol 186:126–130
80. Hu G, Gong A-Y, Roth AL et al (2013) Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. PLoS Pathog 9:e1003261
81. Kapsogeorgou EK, Abu‐Helu RF, Moutsopoulos HM, Manoussakis MN (2005) Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins. Arthritis Rheum 52:1517–1521
82. Masyuk AI, Huang BQ, Ward CJ et al (2010) Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. Am J Physiol Gastrointest Liver Physiol 299:G990–G999
83. Gershwin ME, Mackay I, Sturgess A, Coppel R (1987) Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138:3525–3531
84. Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261–1273
85. Ri F (2005) Sjögren’s syndrome. Lancet 366:321–331
86. Harada K, Van de Water J, Leung PS et al (1997) In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 25:791–796
87. Golovanova EV, Il'chenko L, Tsaregorodtseva TM, Serova TI, Gudkova RB (2004) Cytokines in primary biliary cirrhosis (diagnostic and prognostic value). Ter Arkh 76:8–11
88. Berg PA, Klein R, Rocken M (1997) Cytokines in primary biliary cirrhosis. Semin Liver Dis 17:115–123
89. Barak V, Selmi C, Schlesinger M et al (2009) Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. J Autoimmun 33:178–182
90. Skopouli FN, Moutsopoulos HM (1995) Cytokines in Sjogren's syndrome. Ann Med Intern (Paris) 146:219–222
91. Spengler U, Möller A, Jung MC et al (1992) T lymphocytes from patients with primary biliary cirrhosis produce reduced amounts of lymphotoxin, tumor necrosis factor and interferon-γ upon mitogen stimulation. J Hepatol 15:129–135
92. Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM (1996) Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 80:311–320
93. Harada K, Van de Water J, Leung P et al (1997) In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 25:791–796
94. Sekiya H, Komatsu T, Isono E et al (1999) Decrease in the prevalence of IL-4-producing CD4+ T cells in patients with advanced stage of primary biliary cirrhosis. Am J Gastroenterol 94:3589–3594
95. Shimoda S, Miyakawa H, Nakamura M et al (2008) CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun 31:110–115
96. Wu AJ, Chen ZJ, Tsokos M, O'Connell BC, Ambudkar IS, Baum BJ (1996) Interferon‐γ induced cell death in a cultured human salivary gland cell line. J Cell Physiol 167:297–304
97. Kamachi M, Kawakami A, Yamasaki S et al (2002) Regulation of apoptotic cell death by cytokines in a human salivary gland cell line: distinct and synergistic mechanisms in apoptosis induced by tumor necrosis factor α and interferon γ. J Lab Clin Med 139:13–19
98. Matsumura R, Umemiya K, Goto T et al (1999) Interferon gamma and tumor necrosis factor alpha induce Fas expression and anti-Fas mediated apoptosis in a salivary ductal cell line. Clin Exp Rheumatol 18:311–318
99. Mitsias D, Tzioufas A, Veiopoulou C et al (2002) The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren’s syndrome. Clin Exp Immunol 128:562–568
100. Lan RY, Salunga TL, Tsuneyama K et al (2009) Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 32:43–51
101. Rong G, Zhou Y, Xiong Y et al (2009) Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol 156:217–225
102. Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S (2008) Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren’s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 181:2898–2906
103. Mieliauskaite D, Dumalakiene I, Rugiene R, Mackiewicz Z. (2012) Expression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjögren's syndrome. Clin Dev Immunol. doi:10.1155/2012/187258
104. Hemdan NY, Birkenmeier G, Wichmann G et al (2010) Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev 9:785–792
105. Yang CY, Ma X, Tsuneyama K et al (2014) IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology 59:1944–1953
106. Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjögren’s syndrome immunopathogenesis. Am J Pathol 175:1167–1177
107. Tan X, Sun S, Liu Y et al (2014) Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome. Eye 28:608–613
108. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24:99–146
109. Kizu Y, Sakurai H, Katagiri S et al (1996) Immunohistological analysis of tumour growth factor beta 1 expression in normal and inflamed salivary glands. J Clin Pathol 49:728–732
110. Sharma R, Zheng L, Guo X, Fu SM, Ju ST, Jarjour WN (2006) Novel animal models for Sjogren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice. J Autoimmun 27:289–296
111. McCartney-Francis NL, Mizel DE, Redman RS et al (1996) Autoimmune Sjögren's-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides. J Immunol 157:1306–1312
112. McCartney-Francis NL, Mizel DE, Frazier-Jessen M, Kulkarni AB, McCarthy JB, Wahl SM (1997) Lacrimal gland inflammation is responsible for ocular pathology in TGF-beta 1 null mice. Am J Pathol 151:1281
113. Nandula SR, Amarnath S, Molinolo A et al (2007) Female mice are more susceptible to developing inflammatory disorders due to impaired transforming growth factor β signaling in salivary glands. Arthritis Rheum 56:1798–1805
114. Oertelt S, Lian ZX, Cheng CM et al (2006) Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 177:1655–1660
115. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485–517
116. Van Snick J (1990) Interleukin-6: an overview. Annu Rev Immunol 8:253–278
117. Taga T, Kishimoto T (1997) Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797–819
118. Yoon K-C, Jeong I-Y, Park Y-G, Yang S-Y (2007) Interleukin-6 and tumor necrosis factor-[alpha] levels in tears of patients with dry eye syndrome. Cornea 26:431–437
119. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M (2001) Elevated interleukin‐6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology 40:656–661
120. Boras VV, Cikes N, Lukac J, Cekić-Arambasin A, Virag M, Bosnjak A (2003) The significance of salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with Sjogren's syndrome. Coll Antropol 28:305–309
121. Kawanami T, Sawaki T, Sakai T et al (2012) Skewed production of IL-6 and TGFβ by cultured salivary gland epithelial cells from patients with Sjögren's syndrome. PLoS ONE 7:e45689
122. Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Wakita T, Ida N (1993) Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis. Gastroenterol Jpn 28:18–24
123. Matsumoto K, Fujii H, Michalopoulos G, Fung JJ, Demetris AJ (1994) Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: Interleukin‐6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology 20:376–382
124. Nagano T, Yamamoto K, Matsumoto S et al (1999) Cytokine profile in the liver of primary biliary cirrhosis. J Clin Immunol 19:422–427
125. Itoh S, Matsuzaki Y, Kimura T et al (2000) Cytokine profile of liver-infiltrating CD4+ T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction. J Gastroenterol Hepatol 15:443–451
126. Martinez OM, Villanueva JC, Gershwin ME, Krams SM (1995) Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 21:113–119
127. Zhang W, Tsuda M, Yang GX et al (2010) Deletion of interleukin‐6 in mice with the dominant negative form of transforming growth factor β receptor II improves colitis but exacerbates autoimmune cholangitis. Hepatology 52:215–222
128. Jones DE, Palmer JM, Bennett K et al (2002) Investigation of a mechanism for accelerated breakdown of immune tolerance to the primary biliary cirrhosis–associated autoantigen, pyruvate dehydrogenase complex. Lab Investig 82:211–219
129. Varin M-M, Le Pottier L, Youinou P, Saulep D, Mackay F, Pers J-O (2010) B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. Autoimmun Rev 9:604–608
130. Lindgren S, Eriksson S (1982) IgM in primary biliary cirrhosis. J Lab Clin Med 99:636–645
131. Tsuda M, Moritoki Y, Lian ZX et al (2012) Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Hepatology 55:512–521
132. Meijer JM, Meiners P, Vissink A et al (2010) Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double‐blind, placebo‐controlled trial. Arthritis Rheum 62:960–968
133. Carubbi F, Alunno A, Cipriani P, et al. (2014) Rituximab in primary Sjögren's syndrome: a ten-year journey. Lupus 23:1337–1349
134. Meiners PM, Vissink A, Kallenberg CG, Kroese FG, Bootsma H (2011) Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point? Expert Opin Biol Ther 11:1381–1394
135. Myers RP, Swain MG, Lee SS, Shaheen AA, Burak KW (2013) B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid. Am J Gastroenterol 108:933–941
136. James SP, Jones EA, Hoofnagle JH, Strober W (1985) Circulating activated B cells in primary biliary cirrhosis. J Clin Immunol 5:254–260
137. Nouri-Aria KT, Hegarty JE, Neuberger J, Eddleston AL, Williams R (1985) In vitro studies on the mechanism of increased serum IgM levels in primary biliary cirrhosis. Clin Exp Immunol 61:297–304
138. Migita K, Ilyassova B, Kovzel EF et al (2010) Serum BAFF and APRIL levels in patients with PBC. Clin Immunol 134:217–225
139. Schiemann B, Gommerman JL, Vora K et al (2001) An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111–2114
140. Groom J, Kalled SL, Cutler AH et al (2002) Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 109:59–68
141. Batten M, Groom J, Cachero TG et al (2000) BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192:1453–1466
142. Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X (2004) Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. J Pathol 202:496–502
143. Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K (2005) Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren’s syndrome. J Clin Immunol 25:189–201
144. Migita K, Ilyassova B, Kovzel EF et al (2010) Serum BAFF and APRIL levels in patients with PBC. Clin Immunol 134:217–225
145. Lied G, Berstad A (2011) Functional and clinical aspects of the B‐cell‐activating factor (BAFF): a narrative review. Scand J Immunol 73:1–7
146. Hansen A, Lipsky PE, Dorner T (2007) B cells in Sjogren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 9:218
147. Szodoray P, Alex P, Jonsson MV et al (2005) Distinct profiles of Sjogren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol 117:168–176
148. Sutherland AP, Mackay F, Mackay CR (2006) Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas. Pharmacol Ther 112:774–786
149. Mariette X, Roux S, Zhang J et al (2003) The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann Rheum Dis 62:168–171
150. Zhang B, Hu M, Zhang P et al (2013) BAFF promotes regulatory T-cell apoptosis and blocks cytokine production by activating B cells in primary biliary cirrhosis. Braz J Med Biol Res 46:433–439
151. Ando Y, Yang GX, Kenny TP et al (2013) Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-beta receptor type II mouse. J Autoimmun 41:111–119
152. Chang CH, Chen YC, Yu YH et al (2014) Innate immunity drives xenobiotic-induced murine autoimmune cholangitis. Clin Exp Immunol 177:373–380
153. Chen RC, Naiyanetr P, Shu SA et al (2013) Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology 57:1498–1508
154. Gershwin ME, Krawitt EL (2014) Autoimmune hepatitis: 50 years of (slow) progress. Hepatology 59:754–756
155. Hirschfield GM, Gershwin ME (2013) The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol 8:303–330
156. Huang W, Kachapati K, Adams D et al (2014) Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells. J Autoimmun 50:123–134
157. Hudspeth K, Pontarini E, Tentorio P et al (2013) The role of natural killer cells in autoimmune liver disease: a comprehensive review. J Autoimmun 46:55–65
158. Invernizzi P, Gershwin ME (2014) New therapeutics in primary biliary cirrhosis: will there ever be light? Liver Int 34:167–170
159. Kawata K, Yang GX, Ando Y et al (2013) Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFbetaRII mice. Hepatology 58:1094–1104
160. Leung PS, Wang J, Naiyanetr P et al (2013) Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. J Autoimmun 41:79–86
161. Liaskou E, Hirschfield GM, Gershwin ME (2014) Mechanisms of tissue injury in autoimmune liver diseases. Semin Immunopathol 36:553–568
162. Lleo A, Oertelt-Prigione S, Bianchi I et al (2013) Y chromosome loss in male patients with primary biliary cirrhosis. J Autoimmun 41:87–91
163. Lleo A, Zhang W, McDonald WH et al (2014) Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology 60:1314–1323
164. Mayer CT, Tian L, Hesse C et al (2014) Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals. J Autoimmun 50:23–32
165. Moteki S, Leung PS, Coppel RL et al (1996) Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 24:97–103
166. Ridgway WM, Gershwin ME (2014) Prometheus unbound: NKT cells inhibit hepatic regeneration. Hepatology 60:1133–1135
167. Wang J, Budamagunta MS, Voss JC et al (2013) Antimitochondrial antibody recognition and structural integrity of the inner lipoyl domain of the E2 subunit of pyruvate dehydrogenase complex. J Immunol 191:2126–2133
168. Wang L, Sun Y, Zhang Z et al (2015) CXCR5(+) CD4(+) T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology 61:627–638
169. Wang L, Wang FS, Chang C, Gershwin ME (2014) Breach of tolerance: primary biliary cirrhosis. Semin Liver Dis 34:297–317
170. Wang Q, Selmi C, Zhou X et al (2013) Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 41:140–145
171. Yao Y, Yang W, Yang YQ et al (2014) Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Ralpha(-/-) mice. J Autoimmun 51:99–108
172. Zhang J, Zhang W, Leung PS et al (2014) Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology 60:1708–1716
173. Zhao M, Liu S, Luo S et al (2014) DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun 54:127–136
174. Jones DE (2004) Primary biliary cirrhosis. Autoimmunity 37:325–328
175. Tanaka A, Nezu S, Uegaki S et al (2007) The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis. Ann N Y Acad Sci 1107:259–270
176. Matsumura S, Van de Water J, Leung P et al (2004) Caspase induction by IgA antimitochondrial antibody: IgA‐mediated biliary injury in primary biliary cirrhosis. Hepatology 39:1415–1422
177. Reynoso‐Paz S, Leung PS, Van de Water J et al (2000) Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis. Hepatology 31:24–29
178. Palmer J, Doshi M, Kirby J, Yeaman S, Bassendine M, Jones D (2000) Secretory autoantibodies in primary biliary cirrhosis (PBC). Clin Exp Immunol 122:423–428
179. Ikuno N, Mackay IR, Jois J, Omagari K, Rowley MJ (2001) Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis. J Gastroenterol Hepatol 16:1390–1394
180. Dorner T, Feist E, Held C, Conrad K, Burmester GR, Hiepe F (1996) Differential recognition of the 52-kd Ro(SS-A) antigen by sera from patients with primary biliary cirrhosis and primary Sjogren's syndrome. Hepatology 24:1404–1407
181. Mytilinaiou M, Meyer W, Komorowski L et al (2010) P05 B-cell epitope mapping of anti-ro-52 responses in patients with primary biliary cirrhosis. Gut 59:A13–A14
182. Molina V, Shoenfeld Y (2005) Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38:235–245
183. Stefan M, Zhang W, Concepcion E, Yi Z, Tomer Y (2014) DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology. J Autoimmun 50:33–37
184. Svendsen AJ, Hjelmborg JV, Kyvik KO et al (2013) The impact of genes on the occurrence of autoantibodies in rheumatoid arthritis. A study on disease discordant twin pairs. J Autoimmun 41:120–125
185. Bogdanos DP, Smyk DS, Rigopoulou EI et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38:J156–J169
186. D'Elios MM, Appelmelk BJ, Amedei A, Bergman MP, Del Prete G (2004) Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med 10:316–323
187. Coppel RL, Gershwin M (1995) Primary biliary cirrhosis: the molecule and the mimic. Immunol Rev 144:17–49
188. Van de Water J, Turchany J, Leung P et al (1993) Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Investig 91:2653–2664
189. Szymula A, Rosenthal J, Szczerba BM, Bagavant H, Fu SM, Deshmukh US (2014) T cell epitope mimicry between Sjögren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol 152:1–9
190. Bogdanos D-P, Baum H, Grasso A et al (2004) Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol 40:31–39
191. Selmi C, Balkwill DL, Invernizzi P et al (2003) Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38:1250–1257
192. Shapira Y, Agmon-Levin N, Renaudineau Y et al (2012) Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden. Exp Mol Pathol 93:386–390
193. Morshed SA, Nishioka M, Saito I, Komiyama K, Moro I (1992) Increased expression of Epstein-Barr virus in primary biliary cirrhosis patients. Gastroenterol Jpn 27:751–758
194. Bogdanos DP, Pares A, Rodes J, Vergani D (2004) Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. Am J Gastroenterol 99:763–764, author reply 765
195. Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya J, Shoenfeld Y (2007) Epstein–Barr virus and cytomegalovirus in autoimmune diseases. Ann N Y Acad Sci 1108:567–577
196. Xie K, Snyder M (1995) Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus. Proc Natl Acad Sci 92:1639–1643
197. Croia C, Astorri E, Murray-Brown W et al (2014) Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjogren's syndrome. Arthritis Rheumatol 66:2545–2557
198. Inoue H, Tsubota K, Ono M et al (2001) Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome. J Immunol 166:5801–5809
199. Mariette X, Gozlan J, Clerc D, Bisson M, Morinet F (1991) Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjogren's syndrome. Am J Med 90:286–294
200. Inoue N, Harada S, Miyasaka N, Oya A, Yanagi K (1991) Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjögren's syndrome and with rheumatoid arthritis. J Infect Dis 164:22–28
201. Fox RI, Pearson G, Vaughan JH (1986) Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. J Immunol 137:3162–3168
202. Pflugfelder SC, Crouse CA, Monroy D, Yen M, Rowe M, Atherton SS (1993) Epstein-Barr virus and the lacrimal gland pathology of Sjogren's syndrome. Am J Pathol 143:49–64
203. Fleck M, Kern ER, Zhou T, Lang B, Mountz JD (1998) Murine cytomegalovirus induces a Sjogren's syndrome-like disease in C57Bl/6-lpr/lpr mice. Arthritis Rheum 41:2175–2184
204. Burns JC (1983) Persistent cytomegalovirus infection–the etiology of Sjogren's syndrome. Med Hypotheses 10:451–460
205. Zhu J, Newkirk MM (1994) Viral induction of the human autoantigen calreticulin. Clin Invest Med 17:196–205
206. El Miedany YM, Baddour M, Ahmed I, Fahmy H (2005) Sjogren's syndrome: concomitant H. pylori infection and possible correlation with clinical parameters. Joint Bone Spine 72:135–141
207. Shapira Y, Agmon-Levin N, Selmi C et al (2012) Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. J Autoimmun 39:112–116
208. Parke AL (2000) Sjogren's syndrome: a women's health problem. J Rheumatol Suppl 61:4–5
209. Hewagama A, Gorelik G, Patel D et al (2013) Overexpression of X-linked genes in T cells from women with lupus. J Autoimmun 41:60–71
210. Shim GJ, Warner M, Kim HJ et al (2004) Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proc Natl Acad Sci U S A 101:12628–12633
211. Verthelyi D (2001) Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 1:983–993
212. Cutolo M, Sulli A, Seriolo B, Accardo S, Masi A (1994) Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 13:217–226
213. Beato M, Sánchez-Pacheco A (1996) Interaction of steroid hormone receptors with the transcription initiation complex. Endocr Rev 17:587–609
214. Alvaro D, Alpini G, Onori P et al (2000) Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology 119:1681–1691
215. Isse K, Specht SM, Lunz JG, Kang LI, Mizuguchi Y, Demetris AJ (2010) Estrogen stimulates female biliary epithelial cell interleukin‐6 expression in mice and humans. Hepatology 51:869–880
216. Ishimaru N, Arakaki R, Yoshida S, Yamada A, Noji S, Hayashi Y (2008) Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy. J Exp Med 205:2915–2927
217. Mostafa S, Seamon V, Azzarolo AM (2012) Influence of sex hormones and genetic predisposition in Sjogren's syndrome: a new clue to the immunopathogenesis of dry eye disease. Exp Eye Res 96:88–97
218. Bao Y, Cao X (2014) The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review. J Autoimmun 55C:10–23
219. Chen S, Liu Y, Shi G (2014) Anti-CD20 antibody in primary Sjogren's syndrome management. Curr Pharm Biotechnol 15:535–541
220. Isaksen K, Jonsson R, Omdal R (2008) Anti-CD20 treatment in primary Sjogren's syndrome. Scand J Immunol 68:554–564
221. Lahiri A, Varin MM, Le Pottier L et al (2014) Specific forms of BAFF favor BAFF receptor-mediated epithelial cell survival. J Autoimmun 51:30–37
222. Francois A, Gombault A, Villeret B, et al. (2015) B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis. J Autoimmun 56:1–11
223. Cornec D, Jamin C, Pers JO (2014) Sjogren's syndrome: where do we stand, and where shall we go? J Autoimmun 51:109–114
224. Golmia APF, Martin R, Hislop C, Scheinberg M (2014) Disappearance of cryoproteins in the sera of a patient with SLE after treatment with blisibimod, a novel subcutaneous anti-B cell therapy. Rheumatology 53:957–958
225. Seror R, Theander E, Bootsma H et al (2014) Outcome measures for primary Sjogren's syndrome: a comprehensive review. J Autoimmun 51:51–56
226. Fukuo Y, Takagi S, Akaishi H, Kanbara R, Terashi A (1997) Dual effects of bezafibrate on lipid metabolism and hepatobiliary enzymes. Clin Drug Investig 14:125–131
227. Kanda T, Yokosuka O, Imazeki F, Saisho H (2003) Bezafibrate treatment: a new medical approach for PBC patients? J Gastroenterol 38:573–578
228. Gauna AE, Cha S (2013) Costimulatory Molecules in Rheumatic Diseases Revisited with an Emphasis on Their Roles in Autoimmune Sjögren’s Syndrome. In: Stanilova S (ed) Genes and Autoimmunity - Intracellular Signaling and Microbiome Contribution, InTech. doi:10.5772/54480
229. Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X (2010) Treatment of primary Sjögren syndrome: a systematic review. JAMA 304:452–460
230. Tsuneyama K, Van De Water J, Yamazaki K et al (1997) Primary biliary cirrhosis an epithelitis: evidence of abnormal salivary gland immunohistochemistry. Autoimmunity 26:23–31
231. Asvesti C, Hadziyannis SJ, Papadopoulos S et al (1994) Sweat gland carcinoma in a patient with sarcoidosis and primary biliary cirrhosis. Dermatology 189:198–202
232. Li A, Wang Y, Deng Z (2014) Concurrent autoimmune pancreatitis and primary biliary cirrhosis: a rare case report and literature review. BMC Gastroenterol 14:10
233. Dohmen K, Shigematsu H, Miyamoto Y, Yamasaki F, Irie K, Ishibashi H (2002) Atrophic corpus gastritis and Helicobacter pylori infection in primary biliary cirrhosis. Dig Dis Sci 47:162–169